Br J Cancer:miRNA差异表达可能用于黑色素瘤的诊断或预后指标

2012-07-11 Beyond 生物谷

恶性黑色素瘤的发病率正在逐年上升,并且其上升速度比任何其他癌症都要快。皮肤切除活检仍然是黑色素瘤诊断和预后判断的标准方法。良性和恶性病变组织之间有显著的形态重叠,肿瘤的厚度并不总是一个准确的预测指标。 因此确定新的分子标记物以支持组织学检查非常有必要,近日研究人员对不同病理阶段的福尔马林固定、石蜡包埋的样本进行微陈列分析,以便识别差异表达的微小RNA(miRNA)。相关研究论文发表在Britis

恶性黑色素瘤的发病率正在逐年上升,并且其上升速度比任何其他癌症都要快。皮肤切除活检仍然是黑色素瘤诊断和预后判断的标准方法。良性和恶性病变组织之间有显著的形态重叠,肿瘤的厚度并不总是一个准确的预测指标。

因此确定新的分子标记物以支持组织学检查非常有必要,近日研究人员对不同病理阶段的福尔马林固定、石蜡包埋的样本进行微陈列分析,以便识别差异表达的微小RNA(miRNA)。相关研究论文发表在British Journal of Cancer杂志上。

采用QRT-PCR验证这些微小RNA的差异表达,miRNA的功能学研究采用黑色素瘤细胞转染能调节miRNA表达的miRNA前体或抑制剂来开展。结果发现有20个miRNA在良性痣和原发性或转移性黑色瘤中存在显著差异性表达,而其中大部分在黑色素瘤中是下调的,而只有2个miRNA即miR-203和miR-205在原发性和转移性黑色素瘤中是差异表达的。

在体外试验中,抑制过度的miR-200C和miR-205能显著抑制黑色素瘤细胞的克隆集落形成能力,抑制过表达miR-211既能集落形成能力,也能抑制黑色素瘤细胞的侵袭。该研究所确定的一系列miRNA差异表达可能用于黑色素瘤的诊断或预后指标,其中3个miRNAs(即miR-200c、miR-205和miR-211)发挥肿瘤抑制基因的功能。

doi:10.1038/bjc.2011.568
PMC:
PMID:

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.

Xu Y, Brenn T, Brown ER, Doherty V, Melton DW.

BACKGROUND:

The incidence of malignant melanoma is increasing faster than that for any other cancer. Histological examination of skin excision biopsies remains the standard method for melanoma diagnosis and prognosis. Significant morphological overlap between benign and malignant lesions complicates diagnosis, and tumour thickness is not always an accurate predictor of prognosis.

METHODS:

To identify improved molecular markers to support histological examination, we used microarray analysis of formalin-fixed and paraffin-embedded samples from different stages of melanomagenesis to identify differentially expressed microRNAs (miRNAs). Differential expression was validated by qRT-PCR, and functional studies were carried out after transfection of miRNA precursors or inhibitors into melanoma cells to modulate miRNA expression.

RESULTS:

In all, 20 miRNAs showed highly significant differential expression between benign naevi and either primary or metastatic melanomas, the majority being downregulated in melanoma, whereas only 2 miRNAs, namely miR-203 and miR-205, were differentially expressed between primary and metastatic melanomas. In functional in vitro assays, overexpression of miR-200c and miR-205 inhibited anchorage-independent colony formation and overexpression of miR-211 inhibited both anchorage-independent colony formation and invasion.

CONCLUSION:

We have identified a series of differentially expressed miRNAs that could be useful as diagnostic or prognostic markers for melanoma and have shown that three miRNAs (namely miR-200c, miR-205 and miR-211) act as tumour suppressors.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
    2012-11-11 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
    2013-03-19 smallant2002
  5. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
    2012-07-13 Homburg
  6. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1798635, encodeId=8e471e98635d8, content=<a href='/topic/show?id=ae38696503a' target=_blank style='color:#2F92EE;'>#用于黑色#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69650, encryptionId=ae38696503a, topicName=用于黑色)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ce4238, createdName=dangious, createdTime=Thu Mar 07 17:13:00 CST 2013, time=2013-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649190, encodeId=6db5164919008, content=<a href='/topic/show?id=591d48262d1' target=_blank style='color:#2F92EE;'>#差异表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48262, encryptionId=591d48262d1, topicName=差异表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7bc23772344, createdName=mfx807, createdTime=Wed Mar 27 07:13:00 CST 2013, time=2013-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680207, encodeId=9389168020ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Sun Nov 11 18:13:00 CST 2012, time=2012-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930356, encodeId=8e17193035613, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Mar 19 01:13:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312243, encodeId=e61513122435e, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374158, encodeId=6c0413e415804, content=<a href='/topic/show?id=8de610018644' target=_blank style='color:#2F92EE;'>#预后指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100186, encryptionId=8de610018644, topicName=预后指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca3c375, createdName=jwf_2001, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558627, encodeId=36c9155862e64, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564636, encodeId=1b081564636ad, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Fri Jul 13 03:13:00 CST 2012, time=2012-07-13, status=1, ipAttribution=)]

相关资讯

ASCO 2012:两大新药治疗BRAF突变黑色素瘤疗效显著

       美国临床肿瘤学会(ASCO)年会公布的两项III期临床研究显示,与化疗相比,trametinib和dabrafenib这两种通过干扰BRAF通路信号发挥作用的新型口服靶向药物,分别使携带BRAF突变的晚期黑色素瘤患者的进展或死亡风险降低55%和70%。此外,这些药物的安全性也较好。因此,trametinib和dabrafenib有望与vemur

肿瘤免疫治疗时代已经到来?

       离最早研究者提出可以训练机体免疫系统自己杀伤肿瘤的理论,已经过去100 多年,该领域顶级专家认为,这一理论会在明后年最终证实自己。       美国Dana-Farber 癌症中心Glenn Dranoff 教授指出,“我们已经进入了一个新的时期,免疫治疗将成为抗肿

Mol Cancer Res:GSK-3或成黑色素瘤治疗新靶点

糖原合成酶激酶-3(glycogen synthase kinase-3,GSK-3)是一种多功能的丝氨酸/苏氨酸蛋白激酶,是细胞内多种信号转导通路中的重要成分,不仅参与细胞内糖代谢过程而且还参与细胞增殖、细胞分化和细胞凋亡等多种重要生理过程。 GSK-3活性受多种机制调节,其活性调节异常时可引起多种重大疾病如糖尿病、神经退行性疾病和肿瘤等。GSK-3已成为许多疾病治疗靶点,目前针对GSK-3靶

Nature:癌症逃避药物治疗之谜

       癌症最可怕的特点之一就是在治疗后能够复发。对于许多类型的癌症,包括称之为黑色素瘤的皮肤癌,个体化药物能够在实验室中根除癌细胞,然而在患者体内却只生成局部的暂时的反应。长期以来癌症研究领域急待解析的一个问题就是:癌症是如何逃避药物治疗的?        来自博德研究所、达纳法伯癌症研究所和麻省总医院的

Cancer Cell:LKB1基因失活驱动黑色素瘤转移

为什么某些癌症会迅速蔓延到其他器官,而某些人却不发生转移?Norman Sharpless博士,领导的UNC研究团队近日确定了一个关键基因开关,该基因决定了一种致命的皮肤癌--黑色素瘤是否会发生转移扩散。 黑色素瘤(melanoma)又称恶性黑色素瘤,是一种能产生黑色素的高度恶性肿瘤。大多见于30岁以上成年人,发生于皮肤、粘膜和内脏器官。黑色素瘤的预后多数较差,晚期可有淋巴道及血液转移。黑色素瘤

NICE拒绝推荐威罗菲尼治疗黑色素瘤

       英国国立健康和临床优化研究所(Nice)决定不推荐威罗菲尼(Zelboraf)作为黑色素瘤患者的治疗选择,理由是该药价格太过昂贵,这一决定已受到皮肤癌患者支持小组的批评。 威罗菲尼(Zelboraf)        Factor 50公司敦促Nice重新考虑其不推荐该药物的决定,因为此药可能是一个